Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.

Lanceley A, Eagle Z, Ogden G, Gessler S, Razvi K, Ledermann JA, Side L.

Int J Gynecol Cancer. 2012 Feb;22(2):254-9. doi: 10.1097/IGC.0b013e3182392714.

PMID:
22274317
3.
4.

Is family history related to preventive health behaviors and medical management in breast cancer patients?

Madlensky L, Flatt SW, Bardwell WA, Rock CL, Pierce JP; WHEL Study group..

Breast Cancer Res Treat. 2005 Mar;90(1):47-54.

PMID:
15770526
5.

The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.

Komata D, Yahata T, Kodama S, Koyama Y, Takeda N, Tajima K, Makino H, Sato N, Muto I, Hatakeyama K, Tanaka K.

J Obstet Gynaecol Res. 2009 Oct;35(5):912-7. doi: 10.1111/j.1447-0756.2009.01090.x.

PMID:
20149041
6.

Family history of cancer in Brazil: is it being used?

Viana DV, Góes JR, Coy CS, de Lourdes Setsuko Ayrizono M, Lima CS, Lopes-Cendes I.

Fam Cancer. 2008;7(3):229-32. doi: 10.1007/s10689-008-9180-1. Epub 2008 Jan 10.

PMID:
18193339
7.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
8.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
9.
10.

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4.

11.

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A.

J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23.

PMID:
11504767
12.

Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.

Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E.

Breast J. 2003 Jan-Feb;9(1):19-25.

PMID:
12558666
13.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.

Cancer. 2005 Dec 15;104(12):2807-16.

14.

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E.

J Natl Cancer Inst. 1997 Feb 5;89(3):227-38.

PMID:
9017003
15.

Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.

Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D.

BMJ. 1989 Dec 16;299(6714):1487-91.

16.

Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.

Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J, Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group..

J Natl Cancer Inst. 2010 Dec 15;102(24):1874-8. doi: 10.1093/jnci/djq443. Epub 2010 Nov 23.

PMID:
21098759
17.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology..

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
18.

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P.

Gynecol Oncol. 2002 Oct;87(1):52-6.

PMID:
12468342
19.

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.

Harvey SL, Milne RL, McLachlan SA, Friedlander ML, Birch KE, Weideman P; kConFab Investigators., Goldgar D, Hopper JL, Phillips KA.

Breast Cancer Res Treat. 2011 Dec;130(3):1057-61. doi: 10.1007/s10549-011-1733-6. Epub 2011 Aug 18.

PMID:
21850394
20.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force..

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895

Supplemental Content

Support Center